1.35
price up icon0.00%   0.00
after-market After Hours: 1.37 0.02 +1.48%
loading
InspireMD Inc. stock is traded at $1.35, with a volume of 80,809. It is up +0.00% in the last 24 hours and down -18.18% over the past month. InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.
See More
Previous Close:
$1.35
Open:
$1.36
24h Volume:
80,809
Relative Volume:
2.21
Market Cap:
$63.18M
Revenue:
$8.98M
Net Income/Loss:
$-48.79M
P/E Ratio:
-1.6939
EPS:
-0.797
Net Cash Flow:
$-36.77M
1W Performance:
-1.46%
1M Performance:
-18.18%
6M Performance:
-43.28%
1Y Performance:
-45.12%
1-Day Range:
Value
$1.3201
$1.37
1-Week Range:
Value
$1.28
$1.42
52-Week Range:
Value
$1.28
$2.9319

InspireMD Inc. Stock (NSPR) Company Profile

Name
Name
InspireMD Inc.
Name
Phone
972 3 6917691
Name
Address
4 Menorat Hamaor Street, Tel Aviv
Name
Employee
36
Name
Twitter
@InspireMD
Name
Next Earnings Date
2026-03-18
Name
Latest SEC Filings
Name
NSPR's Discussions on Twitter

Compare NSPR vs ABT, SYK, MDT, BSX, EW

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
NSPR icon
NSPR
InspireMD Inc.
1.35 63.18M 8.98M -48.79M -36.77M -0.797
ABT icon
ABT
Abbott Laboratories
101.56 175.59B 44.33B 6.50B 7.40B 3.717
SYK icon
SYK
Stryker Corp
341.24 132.47B 25.12B 3.25B 4.28B 8.3984
MDT icon
MDT
Medtronic Plc
87.10 113.14B 35.48B 4.64B 5.41B 3.582
BSX icon
BSX
Boston Scientific Corp
64.61 94.85B 20.08B 2.89B 3.66B 1.9391
EW icon
EW
Edwards Lifesciences Corp
78.20 45.09B 6.07B 1.06B 1.34B 1.8063

InspireMD Inc. Stock (NSPR) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-02-26 Initiated Maxim Group Buy
Jan-07-16 Initiated Rodman & Renshaw Buy
Mar-13-15 Downgrade Oppenheimer Outperform → Perform
Nov-26-13 Initiated Oppenheimer Outperform

InspireMD Inc. Stock (NSPR) Latest News

pulisher
Apr 14, 2026

InspireMD : April 2026 Investor Deck - marketscreener.com

Apr 14, 2026
pulisher
Apr 14, 2026

Shareholder Lawsuit Launched Against InspireMD - National Today

Apr 14, 2026
pulisher
Apr 12, 2026

After plunging 15.2% in 4 weeks, here's why the trend might reverse for InspireMD (NSPR) - MSN

Apr 12, 2026
pulisher
Apr 11, 2026

Form 424B5Prospectus [Rule 424(b)(5)] - ADVFN

Apr 11, 2026
pulisher
Apr 10, 2026

InspireMD (NSPR) asks shareholders to approve 150M→250M share increase - Stock Titan

Apr 10, 2026
pulisher
Apr 08, 2026

After Dropping 15.2% Over the Past Four Weeks, This Is Why InspireMD (NSPR) Could See a Turnaround - Bitget

Apr 08, 2026
pulisher
Apr 08, 2026

After Plunging 15.2% in 4 Weeks, Here's Why the Trend Might Reverse for InspireMD (NSPR) - Yahoo Finance

Apr 08, 2026
pulisher
Apr 08, 2026

InspireMD (NYSE:NSPR) Trading Down 6.7%What's Next? - MarketBeat

Apr 08, 2026
pulisher
Apr 06, 2026

Published on: 2026-04-06 18:18:37 - baoquankhu1.vn

Apr 06, 2026
pulisher
Apr 04, 2026

InspireMD, Inc. Enters Equity Distribution Agreement with BTIG, LLC – SEC 8-K Filing Details (April 2026) - Minichart

Apr 04, 2026
pulisher
Apr 03, 2026

InspireMD Establishes New $75 Million ATM Program - TipRanks

Apr 03, 2026
pulisher
Apr 03, 2026

According to the latest submitted documents, medical device company InspireMD Inc. has signed an equity distribution agreement with the sales agent. - Bitget

Apr 03, 2026
pulisher
Apr 03, 2026

InspireMD Launches $75 Million At-The-Market Equity Program With BTIG - TradingView — Track All Markets

Apr 03, 2026
pulisher
Apr 03, 2026

InspireMD (NSPR) sets $75M BTIG equity distribution agreement - Stock Titan

Apr 03, 2026
pulisher
Apr 03, 2026

InspireMD (NSPR) launches up to $75M ATM program with BTIG as agent - Stock Titan

Apr 03, 2026
pulisher
Apr 03, 2026

NSPR Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 03, 2026
pulisher
Apr 01, 2026

InspireMD to Participate in Upcoming 25th Annual Needham Virtual Healthcare Conference - The Manila Times

Apr 01, 2026
pulisher
Mar 31, 2026

InspireMD to Present at 25th Annual Needham Virtual Healthcare Conference - National Today

Mar 31, 2026
pulisher
Mar 31, 2026

Stroke-device maker InspireMD will speak at Needham's April 14 webcast - Stock Titan

Mar 31, 2026
pulisher
Mar 30, 2026

Stock Market Recap: Is InspireMD Inc stock risky to hold nowMarket Growth Review & Safe Swing Trade Setup Alerts - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 29, 2026

InspireMD Stock Dips On Wider-Than-Expected Q1 Loss, But Retail Is Optimistic - MSN

Mar 29, 2026
pulisher
Mar 27, 2026

Published on: 2026-03-28 05:12:59 - baoquankhu1.vn

Mar 27, 2026
pulisher
Mar 26, 2026

Market Trends: Will InspireMD Inc stock hit new highs in YEAR2026 Technical Overview & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn

Mar 26, 2026
pulisher
Mar 25, 2026

CEO Moves: Will InspireMD Inc stock hit new highs in YEAR2026 Sentiment & Proven Capital Preservation Methods - baoquankhu1.vn

Mar 25, 2026
pulisher
Mar 24, 2026

InspireMD tops Q4 estimates as revenue jumps, shares rise in premarket trading - MSN

Mar 24, 2026
pulisher
Mar 22, 2026

Geopolitics Watch: Can InspireMD Inc keep up with sector leadersMarket Risk Summary & Real-Time Market Sentiment Reports - baoquankhu1.vn

Mar 22, 2026
pulisher
Mar 21, 2026

InspireMD Q2 2025 Earnings Preview - MSN

Mar 21, 2026
pulisher
Mar 20, 2026

InspireMD targets $13M–$15M in 2026 revenue as CGuard Prime gains US traction - MSN

Mar 20, 2026
pulisher
Mar 20, 2026

Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO), Johnson & Johnson (JNJ) and InspireMD (NSPR) - The Globe and Mail

Mar 20, 2026
pulisher
Mar 19, 2026

InspireMD, Inc. (NSPR) reports Q4 loss, beats revenue estimates - MSN

Mar 19, 2026
pulisher
Mar 19, 2026

InspireMD revenue up 62% to USD 3.1M in Q4 2025 - Medical Buyer

Mar 19, 2026
pulisher
Mar 19, 2026

Returns Recap: Can InspireMD Inc outperform in the next rallyDay Trade & Safe Entry Trade Reports - baoquankhu1.vn

Mar 19, 2026
pulisher
Mar 19, 2026

InspireMD Reports 62% Q4 Revenue Growth and Sets 2026 Outlook for CGuard Prime Carotid Stent System - Minichart

Mar 19, 2026
pulisher
Mar 19, 2026

InspireMD’s Growth Hinges on Real CAS Market Size and Physician Adoption - TipRanks

Mar 19, 2026
pulisher
Mar 18, 2026

Earnings call transcript: InspireMD Q4 2025: Revenue Surges, EPS Beats By Investing.com - za.investing.com

Mar 18, 2026
pulisher
Mar 18, 2026

InspireMD earnings beat by $0.05, revenue topped estimates - Investing.com Canada

Mar 18, 2026
pulisher
Mar 18, 2026

InspireMD, Inc. (NSPR) Posts Fourth Quarter Loss, Surpasses Revenue Projections - Bitget

Mar 18, 2026
pulisher
Mar 18, 2026

InspireMD Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 18, 2026
pulisher
Mar 18, 2026

Earnings call transcript: InspireMD Q4 2025: Revenue Surges, EPS Beats - Investing.com

Mar 18, 2026
pulisher
Mar 18, 2026

InspireMD, Inc. Overview: CGuard Carotid Stent Technology, Business Strategy, and Market Leadership in Stroke Prevention 72 - Minichart

Mar 18, 2026
pulisher
Mar 18, 2026

InspireMD Reports Strong Q4 2025 Growth and Expansion - TipRanks

Mar 18, 2026
pulisher
Mar 18, 2026

FDA PMA and global expansion reshape InspireMD (NSPR) carotid focus - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

InspireMD, Inc. (NSPR) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance

Mar 18, 2026
pulisher
Mar 18, 2026

InspireMD, Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com

Mar 18, 2026
pulisher
Mar 18, 2026

InspireMD Q4 net income USD -11.761 million - marketscreener.com

Mar 18, 2026
pulisher
Mar 18, 2026

InspireMD Reports Fourth Quarter and Full Year 2025 Financial Results - Bitget

Mar 18, 2026
pulisher
Mar 18, 2026

INSPIREMD ($NSPR) Releases Q4 2025 Earnings - Quiver Quantitative

Mar 18, 2026
pulisher
Mar 18, 2026

InspireMD (NSPR) revenue climbs 28% in 2025 as net loss widens - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

InspireMD Q4 revenue rises 62%, beats estimates - TradingView

Mar 18, 2026
pulisher
Mar 18, 2026

NSPR: Q4 2025 revenue surged 62% year-over-year, with 2026 revenue growth projected at up to 65% - TradingView

Mar 18, 2026
pulisher
Mar 17, 2026

InspireMD, Inc. (NSPR) Announces Fourth Quarter Loss, Surpasses Revenue Projections - Bitget

Mar 17, 2026

InspireMD Inc. Stock (NSPR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

InspireMD Inc. Stock (NSPR) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Gleason Shane Thomas
Chief Commercial Officer
Jan 28 '26
Sale
1.65
12,395
20,464
1,149,077
Gleason Shane Thomas
Chief Commercial Officer
Jan 22 '26
Sale
1.57
8,411
13,239
1,166,253
Gleason Shane Thomas
Chief Commercial Officer
Jan 29 '26
Sale
1.65
5,000
8,250
1,144,077
Gleason Shane Thomas
Chief Commercial Officer
Jan 27 '26
Sale
1.66
4,781
7,956
1,161,472
Gleason Shane Thomas
Chief Commercial Officer
Jan 30 '26
Sale
1.63
2,900
4,730
1,141,177
Gleason Shane Thomas
Chief Commercial Officer
Jan 20 '26
Sale
1.59
2,955
4,710
1,192,257
Gleason Shane Thomas
Chief Commercial Officer
Jan 15 '26
Sale
1.58
2,909
4,593
1,197,462
Gleason Shane Thomas
Chief Commercial Officer
Jan 16 '26
Sale
1.61
2,250
3,627
1,195,212
Gleason Shane Thomas
Chief Commercial Officer
Feb 02 '26
Sale
1.60
2,000
3,208
1,139,177
Stuka Paul
Director
Dec 09 '25
Buy
1.81
5,073
9,182
391,628
ZBH ZBH
$94.20
price down icon 2.40%
STE STE
$221.50
price down icon 1.48%
$61.54
price down icon 2.24%
PHG PHG
$29.09
price up icon 0.00%
$73.51
price down icon 1.55%
EW EW
$78.20
price up icon 0.00%
Cap:     |  Volume (24h):